| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.091 | 48.683 | 12.611 | 20.296 | 4.360 | 33.969 | - |
| Total Income - EUR | - | - | - | 24.970 | 55.942 | 20.321 | 27.207 | 4.360 | 37.154 | - |
| Total Expenses - EUR | - | - | - | 23.815 | 22.676 | 18.667 | 16.639 | 3.185 | 36.299 | - |
| Gross Profit/Loss - EUR | - | - | - | 1.155 | 33.265 | 1.654 | 10.568 | 1.175 | 854 | - |
| Net Profit/Loss - EUR | - | - | - | 1.084 | 32.779 | 1.528 | 10.351 | 1.138 | 515 | - |
| Employees | - | - | - | 1 | 3 | 2 | 2 | 0 | 1 | - |
Check the financial reports for the company - Bioware Technology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 20.755 | 13.099 | 5.734 | 1.051 | 148 | 0 | - |
| Current Assets | - | - | - | 7.110 | 51.096 | 61.638 | 81.969 | 86.576 | 119.358 | - |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | - | - | 7.091 | 49.943 | 61.607 | 81.952 | 86.566 | 105.515 | - |
| Cash | - | - | - | 19 | 1.153 | 31 | 17 | 10 | 13.843 | - |
| Shareholders Funds | - | - | - | 1.108 | 33.865 | 34.751 | 44.331 | 45.607 | 45.983 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 5.523 | 16.765 | 27.024 | 38.688 | 41.117 | 73.375 | - |
| Income in Advance | - | - | - | 21.234 | 13.564 | 5.597 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Bioware Technology S.r.l.